Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Celltrion Healthcare IPO Set To Benefit From Biosimilar Successes

Mar 16 2017

• By Jung Won Shin

US dollars

Related Content

Celltrion Healthcare Aims For IPO After FDA Green Lights Remsima

Apr 16 2015

Celltrion's Truxima First Biosimilar MAB In Oncology To Win EU Approval

Feb 22 2017

Related Companies

Celltrion, Inc.

Johnson & Johnson

Samsung Bioepis Co., Ltd.

Novartis AG

Amgen, Inc.

Pfizer Inc.

Genentech, Inc.

Biogen, Inc.

Additional Topics

South Korea Asia Pacific Commercial Companies Financing Biosimilars BioPharmaceutical

More from South Korea

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window